Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1550 (0.65%) ($6.1550 - $6.1550) on Thu. Sep. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.17% (three month average) | RSI | 48 | Latest Price | $6.1550(0.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.2% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(70%) ARKG(69%) ARKK(67%) IWO(65%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.585% in a week (0% probabilities). VIXM(-50%) VXX(-36%) UUP(-13%) TLT(-6%) IGOV(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.585% (StdDev 3.17%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.56 | 5 Day Moving Average | $6.21(-0.89%) | 10 Day Moving Average | $6.53(-5.74%) | 20 Day Moving Average | $6.56(-6.17%) | To recent high | -30% | To recent low | 5.9% | Market Cap | $509m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |